Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
Chris Vriend, Tim D. van Balkom, Corné van Druningen, Martin Klein, Ysbrand D. van der Werf, Henk W. Berendse, Odile A. van den Heuvel
Abstract
Parkinson's disease (PD) affects the integrity of the dopamine and serotonin system, and is characterized by a plethora of different symptoms, including cognitive impairments of which the pathophysiology is not yet fully elucidated. Investigate the role of the integrity of the dopaminergic and serotonergic system in cognitive functioning in early-stage PD using Single Photon Emission Computed Tomography (SPECT) combined with the radiotracer 123I-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (123I-FP-CIT). We studied the association between cognitive functions and dopamine transporter (DAT) availability in the caudate nucleus and putamen – as a proxy for striatal dopaminergic integrity – and serotonin transporter (SERT) availability as a proxy for serotonergic integrity in the thalamus and hippocampus using bootstrapped multiple regression. One-hundred-and-twenty-nine (129) PD patients underwent a 123I-FP-CIT SPECT scan and a neuropsychological assessment. We showed a positive association between DAT availability in the head of the caudate nucleus and the Stroop Color Word Task – card I (reading words; β = 0.32, P = 0.001) and a positive association between DAT availability in the anterior putamen and the Trail Making Test part A (connecting consecutively numbered circles; β = 0.25, P = 0.02). These associations remained after adjusting for motor symptom severity or volume of the region-of-interest and were most pronounced in medication-naïve PD patients. There were no associations between cognitive performance and SERT availability in the thalamus or hippocampus. We interpret these results as a role for striatal dopamine – and its PD-related decline – in aspects of processing speed.